Bryan, Garnier & Co's News

Oncology White Paper

News published on
October Thursday 20, 2016


Bryan, Garnier & Co recently hosted a special “Oncology Day” with the Institute Curie in Paris. Attended by leading experts in cancer research and treatment as well as strategic investors and fund managers, the subject of immune-oncology was discussed in detail.

The growing importance of biological and immunology therapies is expected to drive the global market for immuno-oncology drugs to over $30 billion by 2020. To help investors understand the key trends, we have captured these insights in a new report.


Click here to download our latest findings >>